Injectable Composite hydrogel overcomes solubility-penetration-retention bottlenecks for lumbar facet joint osteoarthritis by inhibiting NLRP3 inflammasome

Lumbar facet joint osteoarthritis (FJOA) is a leading contributor to back pain, yet current administered therapies are unable to inhibit inflammatory injury of cartilage. The NLRP3 inflammasome drives the degenerative injury of cartilage by generating mature IL-1β, contributing to chondrocyte apoptosis and extracellular matrix degradation. Small‑molecule NLRP3 inhibitor CY09 holds promising anti‑inflammatory potential, but its poor aqueous solubility, insufficient cartilage penetration, and short intra‑articular residence severely restrict intra‑articular application. This study fabricated an injectable composite hydrogel (CY09@ACD/Ca-Alg) by encapsulating CY09 in cationic amino-modified β-cyclodextrin (ACD) inclusion complexes and cross-linking the complexes within a calcium-alginate network. Cy5-labelled ACD formulations showed penetration into deep layer of cartilage explants and in vivo fluorescence tracer revealed prolonged retention of the alginate matrix in rat facet joints up to 28 days. In vitro, CY09@ACD/Ca-Alg reduces NLRP3 inflammasome-associated markers, reduces mature IL-1β secretion, reduces NF-κB activation, and restores the balance between anabolic and catabolic chondrocyte phenotypes. In vivo, intra-articular injection of CY09@ACD/Ca-Alg reduces NLRP3 and Caspase-1 signals and local IL-1β levels, attenuates cartilage erosion, and decreases local inflammatory level. This composite hydrogel platform, combining host-guest solubilization, deep cartilage targeting, and sustained joint retention, provides a potential approach for FJOA.

Authors

Institutions

Publication Details

Journal
Research Square
Published
2026-11-18
DOI
https://doi.org/10.21203/rs.3.rs-11506367/v1
Primary Topic
Osteoarthritis Treatment and Mechanisms
Type
preprint

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Injectable Composite hydrogel overcomes solubility-penetration-retention bottlenecks for lumbar facet joint osteoarthritis by inhibiting NLRP3 inflammasome

Yuxu Wu, Yihe Hu, Zhiyun Feng, Sicheng Huang et al.
4 links
Research Square
Osteoarthritis Treatment and Mechanisms
preprint

Injectable Composite hydrogel overcomes solubility-penetration-retention bottlenecks for lumbar facet joint osteoarthritis by inhibiting NLRP3 inflammasome

Yuxu Wu, Yihe Hu, Zhiyun Feng, Sicheng Huang, Qingqing Zhang, Junrong Lin, Chihao Jin, Kai Zhang
preprint en

Abstract

Lumbar facet joint osteoarthritis (FJOA) is a leading contributor to back pain, yet current administered therapies are unable to inhibit inflammatory injury of cartilage. The NLRP3 inflammasome drives the degenerative injury of cartilage by generating mature IL-1β, contributing to chondrocyte apoptosis and extracellular matrix degradation. Small‑molecule NLRP3 inhibitor CY09 holds promising anti‑inflammatory potential, but its poor aqueous solubility, insufficient cartilage penetration, and short intra‑articular residence severely restrict intra‑articular application. This study fabricated an injectable composite hydrogel (CY09@ACD/Ca-Alg) by encapsulating CY09 in cationic amino-modified β-cyclodextrin (ACD) inclusion complexes and cross-linking the complexes within a calcium-alginate network. Cy5-labelled ACD formulations showed penetration into deep layer of cartilage explants and in vivo fluorescence tracer revealed prolonged retention of the alginate matrix in rat facet joints up to 28 days. In vitro, CY09@ACD/Ca-Alg reduces NLRP3 inflammasome-associated markers, reduces mature IL-1β secretion, reduces NF-κB activation, and restores the balance between anabolic and catabolic chondrocyte phenotypes. In vivo, intra-articular injection of CY09@ACD/Ca-Alg reduces NLRP3 and Caspase-1 signals and local IL-1β levels, attenuates cartilage erosion, and decreases local inflammatory level. This composite hydrogel platform, combining host-guest solubilization, deep cartilage targeting, and sustained joint retention, provides a potential approach for FJOA.

Research Square
First Affiliated Hospital Zhejiang University (CN)
National Natural Science Foundation of China, Science and Technology Department of Zhejiang Province
Good health and well-being
Osteoarthritis Treatment and Mechanisms
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon